
Empagliflozin 10 mg | SGLT2 Inhibitor for Type 2 Diabetes & Cardiometabolic Care
Phoenix Exim β Pharmaceutical Exporter from Nagpur, India
Empasmart 10 mg Tablet contains Empagliflozin 10 mg, an oral medicine belonging to the SGLT2 inhibitor class. It helps lower blood glucose by increasing the amount of glucose removed from the body through urine.
Phoenix Exim, based in Nagpur, India, offers pharmaceutical products for international B2B requirements, including supply support for the USA, UK, Australia, Singapore, Canada, South Korea, and UAE, subject to applicable destination-country regulations.
1. β¦ GENERAL INFORMATION
Empasmart 10 mg Tablet is an oral prescription medicine containing Empagliflozin 10 mg. It belongs to a class of medicines called Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors.
It is primarily used to improve blood-glucose control in adults with type 2 diabetes mellitus, alongside appropriate diet and exercise. Empagliflozin is also used in appropriate adult patients with certain forms of heart failure and chronic kidney disease, depending on the approved indication in the relevant market.
β¨ Product Highlights
Empagliflozin 10 mg
Oral tablet formulation
SGLT2 inhibitor
Primarily used in type 2 diabetes management
Supports glucose control through a kidney-mediated mechanism
Prescription medicine
Manufactured in India
2. π PRODUCT INFORMATION
| Product Detail | Information |
|---|---|
| Brand | Empasmart |
| Strength | 10 mg |
| Active Ingredient | Empagliflozin |
| Dosage Form | Tablet |
| Drug Class | SGLT2 Inhibitor |
| Primary Therapeutic Area | Diabetes Care |
| Route | Oral |
| Manufacturer | Healing Pharma India Pvt. Ltd. |
| Country of Origin | India |
| Supply Base | Nagpur, Maharashtra, India |
Available product listings identify Empasmart 10 mg as Empagliflozin 10 mg, commonly supplied in a strip of 10 tablets.
3. π― USES OF EMPASMART 10 MG
πΉ Type 2 Diabetes Mellitus
Empasmart 10 mg is used to help improve blood-glucose control in adults with type 2 diabetes when diet and exercise alone are not sufficient.
β€οΈ Heart Failure
Empagliflozin is used in appropriate adult patients with heart failure to reduce the risk of cardiovascular death and hospitalization, according to applicable approved indications.
π« Chronic Kidney Disease
Empagliflozin may also be prescribed for eligible adults with chronic kidney disease to help reduce the risk of disease progression and related outcomes.
π Cardiometabolic Management
Because of its effects on glucose and fluid handling, empagliflozin can provide benefits beyond blood-glucose reduction in appropriately selected patients.
4. β BENEFITS OF EMPASMART 10 MG
When prescribed appropriately, Empagliflozin may provide several therapeutic benefits:
β
Helps lower elevated blood-glucose levels
β
Supports improved glycemic control
β
Works independently of insulin secretion
β
Promotes urinary glucose excretion
β
May support modest weight reduction in some patients
β
Can produce a mild reduction in blood pressure in some patients
β
Provides established cardiovascular benefits in eligible patients
β
Provides kidney-related benefits in eligible patients
β
Convenient once-daily oral formulation
The specific benefits depend on the patient's medical condition and the indication for which empagliflozin is prescribed.
5. β οΈ SIDE EFFECTS OF EMPASMART 10 MG
Like all medicines, Empagliflozin can cause side effects.
Possible adverse effects include:
Increased urination
Increased thirst
Urinary tract infections
Genital fungal/yeast infections
Dehydration
Dizziness
Low blood pressure
Changes in kidney function
Low blood glucose, particularly when combined with insulin or certain other diabetes medicines
Rare but serious complications can occur, including diabetic ketoacidosis and serious genital or urinary infections. Seek urgent medical attention if severe symptoms develop.
6. πΈ COMMON SIDE EFFECTS
Commonly reported effects may include:
Increased urination | Increased thirst | Urinary tract infection | Genital yeast infection | Dehydration | Dizziness
The risk of hypoglycemia is generally higher when empagliflozin is used together with insulin or insulin-secretagogue medicines rather than when used alone.
7. π HOW TO USE EMPASMART 10 MG
Take Empasmart exactly as prescribed by your doctor.
General Guidance
1. Take orally
Swallow the tablet with water.
2. Maintain consistency
Take it at approximately the same time each day.
3. Food
Empagliflozin can generally be taken with or without food.
4. Stay adequately hydrated
Because the medicine increases urinary glucose and fluid loss, maintaining appropriate hydration is important.
5. Do not double doses
If you miss a dose, follow the instructions provided by your healthcare professional rather than taking an extra dose.
Do not change the dose or discontinue treatment without medical advice.
8. βοΈ HOW DOES EMPASMART 10 MG WORK?
Empasmart contains Empagliflozin, an SGLT2 inhibitor.
π« Step 1 β Acts on the Kidneys
SGLT2 is responsible for reabsorbing glucose from the urine back into the bloodstream.
π¬ Step 2 β Reduces Glucose Reabsorption
Empagliflozin inhibits SGLT2, reducing the amount of glucose reabsorbed by the kidneys.
π½ Step 3 β More Glucose Leaves Through Urine
As a result, excess glucose is excreted through urine.
π Step 4 β Blood Glucose Falls
This helps reduce elevated blood-glucose levels and improve glycemic control.
The medicine's increased urinary glucose and sodium excretion also contributes to its cardiovascular and kidney-related effects in appropriate patients.
9. π‘οΈ SAFETY ADVICE
βοΈ Prescription Use
Use Empasmart only according to the advice of a qualified healthcare professional.
π§ Maintain Hydration
Empagliflozin increases urination. Dehydration can occur, particularly in people who are elderly, taking diuretics, or experiencing vomiting or diarrhea.
π©Έ Monitor Blood Glucose
Regular glucose monitoring may be required depending on your treatment plan.
π¨ Watch for Ketoacidosis
Seek urgent medical attention if symptoms such as nausea, vomiting, abdominal pain, unusual tiredness, or difficulty breathing occur, particularly during illness or reduced food intake.
π¦ Watch for Infections
Contact a healthcare professional if you develop symptoms of urinary or genital infection.
π« Kidney Function
Kidney function should be assessed and monitored as recommended by your healthcare professional.
π Other Diabetes Medicines
Tell your doctor if you use insulin, sulfonylureas, diuretics, or other medicines that affect blood glucose or fluid balance.
π· Alcohol
Alcohol can contribute to dehydration and may increase certain risks associated with diabetes treatment. Discuss alcohol consumption with your healthcare professional.
π€° Pregnancy
Discuss empagliflozin use with your healthcare professional if pregnant or planning pregnancy.
πΆ Breastfeeding
Consult your healthcare professional before using empagliflozin while breastfeeding.
π₯ Surgery or Acute Illness
Your doctor may recommend temporarily stopping treatment around certain surgical procedures or during serious acute illness. Follow your healthcare professional's instructions.
10. β FREQUENTLY ASKED QUESTIONS
Q1. What is Empasmart 10 mg Tablet?
Empasmart 10 mg is an oral tablet containing Empagliflozin 10 mg, an SGLT2 inhibitor used primarily in the management of type 2 diabetes.
Q2. What is Empasmart 10 mg used for?
It is primarily used to improve blood-glucose control in adults with type 2 diabetes. Empagliflozin also has approved uses for certain patients with heart failure and chronic kidney disease.
Q3. How does Empasmart lower blood sugar?
It blocks SGLT2 in the kidneys, causing more glucose to be removed from the body through urine.
Q4. Does Empasmart increase urination?
Yes. Increased urination can occur because glucose and associated fluid are excreted through the urine.
Q5. Can Empasmart cause low blood sugar?
Empagliflozin alone has a relatively low risk of hypoglycemia, but the risk can increase when it is combined with insulin or certain other diabetes medicines.
Q6. Can Empasmart help with weight?
Some patients may experience modest weight reduction because glucose and calories are lost through urine. It should not be used solely as a weight-loss medicine.
Q7. Can Empasmart be taken with food?
Yes. Empagliflozin can generally be taken with or without food.
Q8. Should I drink more water while taking Empasmart?
Adequate hydration is important, but individual fluid requirements vary. Follow your healthcare professional's advice, particularly if you have heart or kidney disease.
Q9. Can Empasmart be used for type 1 diabetes?
Empagliflozin is not routinely used for type 1 diabetes because of the risk of diabetic ketoacidosis.
Q10. Can Empasmart 10 mg be exported internationally?
International pharmaceutical requirements vary by destination. Buyers should verify product registration, prescription status, import authorization, labeling, documentation, customs requirements, and local regulations before purchasing.
11. π SUBSTITUTE / ALTERNATIVE FOR EMPASMART 10 MG
The closest pharmaceutical alternatives are generally products containing the same active ingredient, Empagliflozin 10 mg, where approved and available.
Possible Alternatives
Other approved Empagliflozin 10 mg Tablets
Other empagliflozin brands
Empagliflozin combination products, when specifically prescribed
Other SGLT2 inhibitors, where clinically appropriate
β οΈ Important
A different SGLT2 inhibitor is not automatically equivalent to Empagliflozin 10 mg.
The appropriate alternative depends on the patient's diagnosis, kidney function, cardiovascular status, other medicines, and local prescribing guidance.
Substitution should be made only under qualified medical supervision.
12. π SEO KEYWORDS
π Primary Product Keywords
Empasmart 10 mg Tablet
Empasmart 10 mg exporter India
Empasmart 10 mg supplier
Empagliflozin 10 mg Tablet
Empagliflozin 10 mg exporter India
Empagliflozin Tablet supplier
Empagliflozin pharmaceutical supplier
Empagliflozin medicine exporter
Empasmart 10 mg pharmaceutical supplier
Empagliflozin 10 mg B2B supplier
πΌ B2B & Wholesale Keywords
Empagliflozin tablet wholesale supplier
Empagliflozin pharmaceutical exporter India
Empasmart diabetes medicine supplier
Type 2 diabetes medicine exporter India
Diabetes care pharmaceutical supplier
SGLT2 inhibitor supplier India
SGLT2 inhibitor exporter India
Empagliflozin B2B pharmaceutical supplier
Diabetes medicine wholesale exporter
Empagliflozin international supplier
π Country-Focused Keywords
Empagliflozin supplier USA
Empagliflozin supplier UK
Empagliflozin supplier Australia
Empagliflozin supplier Canada
Empagliflozin supplier Singapore
Empagliflozin supplier South Korea
Empagliflozin supplier UAE
India diabetes medicine exporter USA
India pharmaceutical exporter UK
India pharmaceutical exporter Australia
India pharmaceutical exporter Canada
India pharmaceutical exporter Singapore
India pharmaceutical exporter South Korea
India pharmaceutical exporter UAE
Nagpur pharmaceutical exporter
π₯ Long-Tail SEO Keywords
Empasmart 10 mg Tablet pharmaceutical exporter from India
Empagliflozin 10 mg Tablet international B2B supplier
Empagliflozin diabetes medicine wholesale supplier India
Empasmart 10 mg diabetes medicine supplier from India
Empagliflozin SGLT2 inhibitor pharmaceutical exporter
Empagliflozin 10 mg global pharmaceutical supplier
Type 2 diabetes medicine B2B exporter from India
Empagliflozin 10 mg supplier from Nagpur India
Diabetes care medicine exporter from Nagpur
Empagliflozin tablet international supply partner
π’ Phoenix Exim Keywords
Phoenix Exim pharmaceutical exporter
Phoenix Exim medicine exporter Nagpur
Phoenix Exim Empasmart supplier
Phoenix Exim Empagliflozin supplier India
Phoenix Exim diabetes medicine exporter
π PHOENIX EXIM β INTERNATIONAL PHARMACEUTICAL SUPPLY
Empasmart 10 mg | Empagliflozin 10 mg | Diabetes Care
Phoenix Exim
Pharmaceutical Exporter from Nagpur, India
π International B2B Supply Support:
πΊπΈ USA | π¬π§ UK | π¦πΊ Australia | πΈπ¬ Singapore | π¨π¦ Canada | π°π· South Korea | π¦πͺ UAE
Keywords







